Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation-Reference-Cited by-同舟云学术

Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation

Published:2024-06-04 Issue:1 Volume:35 Page:
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Subbarayan Rajasekaran¹^ORCID,Srinivasan Dhasarathdev¹,Sadullah Usmani Salman²,Murugan Girija Dinesh³,Ikhlas Shoeb⁴,Srivastav Nityanand⁴,Balakrishnan Ranjith¹,Shrestha Rupendra⁵^ORCID,Chauhan Ankush⁶

Affiliation:

1. Centre for Advanced Biotherapeutics and Regenerative Medicine, Research-FAHS, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India

2. Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA

3. Research and Development, Vopec Pharmaceuticals Pvt Limited, Chennai, India

4. Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA

5. Research and Collaboration, Anka Analytica, Melbourne, Australia

6. Centre for Herbal Pharmacology and Environmental Sustainability, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India

Funder

not receive

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2024.2359028

Reference40 articles.

1. From hematopoietic stem cells to platelets

2. Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC)

3. F104S c-Mpl responds to a transmembrane domain−binding thrombopoietin receptor agonist: Proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents

4. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation

5. Romiplostim